The pharmaceutical industry constantly seeks high-quality, versatile intermediates to synthesize new and effective drugs. Gallic Acid, with its unique chemical structure and biological activities, stands as a pivotal compound in this endeavor. NINGBO INNO PHARMCHEM CO.,LTD. is a premier gallic acid manufacturer, committed to providing the pharmaceutical sector with top-tier raw materials, including gallic acid powder CAS 149-91-7.

Gallic Acid (CAS 149-91-7), chemically known as 3,4,5-trihydroxybenzoic acid, is a highly reactive molecule that serves as a fundamental building block for a wide array of medicinal compounds. Its three hydroxyl groups and carboxyl group make it an ideal starting material for esterification, etherification, and other crucial synthetic reactions. These properties enable the creation of various derivatives with enhanced bioavailability or targeted pharmacological actions, expanding the scope of gallic acid pharmaceutical applications. For drug developers seeking a consistent and high-purity source, finding a reputable gallic acid supplier like NINGBO INNO PHARMCHEM CO.,LTD. is crucial.

The utility of Gallic Acid extends to the synthesis of antioxidants, anti-inflammatory agents, and compounds with antimicrobial properties, all of which are highly relevant in pharmaceutical development. For instance, gallate esters are well-known for their antioxidant capabilities, making them valuable in formulations aimed at combating oxidative stress-related diseases. The demand to buy gallic acid for advanced pharmaceutical research and production underscores its importance in the global drug supply chain.

NINGBO INNO PHARMCHEM CO.,LTD. adheres to rigorous quality control standards, ensuring that our Gallic Acid meets the strict requirements of pharmaceutical grade raw materials. Our commitment as a reliable gallic acid supplier facilitates innovation in drug development, enabling our clients to bring vital new treatments to market. By offering competitive gallic acid price and unwavering quality, we support the industry's pursuit of new therapeutic breakthroughs.